Precision medicine in colorectal cancer: the molecular profile alters treatment strategies by Tran, Nguyen H., Cavalcante, Ludimila L., Lubner, Sam J., Mulkerin, Daniel L., LoConte, Noelle K., Clipson, Linda, Matkowskyj, Kristina A., Deming, Dustin A.

Request full text

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis by Cavalcante, Ludimila L, Cavalcante, Milena L, Murray, Timothy G, Vigoda, Michael M, Piña, Yolanda, Decatur, Christina L, Davis, R Prince, Olmos, Lisa C, Schefler, Amy C, Parrott, Michael B, Alliman, Kyle J, Flynn, Harry W, Moshfeghi, Andrew A

Get full text

Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab by Cavalcante, Milena L, Villegas, Victor M, Gold, Aaron S, Cavalcante, Ludimila L, Lonngi, Marcela, Shah, Nisha V, Murray, Timothy G

Get full text

GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties by Park, Robin, Coveler, Andrew L., Cavalcante, Ludimila, Saeed, Anwaar

Get full text

Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, i... by Cavalcante, Ludimila, Chandana, Sreenivasa, Lakhani, Nehal, Enstrom, Amanda, LeBlanc, Heidi, Schmalz, Joseph, Lengyel, Krisztina, Schneider, Frank, Thomas, Heather, Chisamore, Michael J, Peng, Stanford L, Naumovski, Allison, Davar, Diwakar

Get full text

Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced s... by Davar, Diwakar, Cavalcante, Ludimila, Lakhani, Nehal, Moser, Justin, Millward, Michael, McKean, Meredith, Voskoboynik, Mark, Sanborn, Rachel E, Grewal, Jaspreet S, Narayan, Ajita, Patnaik, Amita, Gainor, Justin F, Sznol, Mario, Enstrom, Amanda, Blanchfield, Lori, LeBlanc, Heidi, Thomas, Heather, Chisamore, Michael J, Peng, Stanford L, Naumovski, Allison

Get full text

A Phase 2 Evaluation of Daratumumab-Based Induction Therapy in Multiple Myeloma Patients with Severe Renal Insufficiency by Harvey, R Donald, Franz, Joseph K, Joseph, Nisha S., Kaufman, Jonathan L., Hitron, Elise, Collins, Hannah, Braga, Catherine, Cavalcante, Ludimila, Maples, Kathryn T., Hofmeister, Craig C, Dhodapkar, Madhav, Lonial, Sagar, Nooka, Ajay K.

Get full text

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies by Carneiro, Benedito A, Cavalcante, Ludimila, Mahalingam, Devalingam, Saeed, Anwaar, Safran, Howard, Ma, Wen Wee, Coveler, Andrew L, Powell, Steven, Bastos, Bruno, Davis, Elizabeth, Sahai, Vaibhav, Mikrut, William, Longstreth, James, Smith, Sheri, Weisskittel, Taylor, Li, Hu, Borden, Brittany A, Harvey, R Donald, Sahebjam, Solmaz, Cervantes, Andrés, Koukol, Austin, Mazar, Andrew P, Steeghs, Neeltje, Kurzrock, Razelle, Giles, Francis J, Munster, Pamela

Get full text

Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease by Cavalcante, Ludimila, Amin, Asim, Lutzky, Jose

Get full text